Drug intelligence / Profile preview

Innofiller

Development stage
Unknown
Lead developer
Vivid Scientific
Modality
Recombinant Proteins and Enzymes
Administration
Intramuscular, Intradermal, Subdermal
01

Overview

Innofiller is an injectable aesthetic product that has been marketed and distributed (notably by the now-closed Vivid-Scientific) as a Botulinum Toxin Type A neuromodulator. Despite a brand name that suggests a dermal filler and some distributor descriptions citing soft-tissue augmentation or volume loss, it is primarily categorized as a neurotoxin. It is used to treat aesthetic indications such as facial wrinkles and fine lines by inducing temporary muscle relaxation. The mechanism of action involves the proteolytic cleavage of SNAP-25, a protein essential for the release of acetylcholine at the neuromuscular junction. Innofiller is typically supplied as a lyophilized powder in 100-unit vials for reconstitution and is administered via intramuscular, intradermal, or subdermal injection. It belongs to the broader class of Korean-manufactured botulinum toxins used in cosmetic medicine.

Brand names
Innofiller
Other names
Inno FillerInnofiller 100UInnofiller100UInnofiller-100UBotulinum Toxin Type A Innofiller
02

Targets

SNAP25 (Synaptosome-associated protein 25)

Beyond the preview

Go deeper on Innofiller.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innofiller.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call